What is the Baloxavir marboxil?

Baloxavir marboxil is , while it's Molecular Formula is C27H23F2N3O7S. Baloxavir Marboxil is a prodrug of S-033447, which is an inhibitor of the cap-dependent endonuclease of influenza A and B viruses.

What is the CAS number for Baloxavir marboxil?

The CAS number of Baloxavir marboxil is 1985606-14-1.

What is Baloxavir marboxil (1985606-14-1) used for?

Baloxavir marboxil is an antiviral drug developed by Shionogi Co., a Japanese pharmaceutical company and Roche for the treatment of influenza A and influenza B infections. The drug was initially approved for use in Japan in February 2018 and approved by the FDA on October 24, 2018 for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours Label. Baloxavir marboxil, a cap-endonuclease inhibitor, has a unique mechanism of action when compared to the currently existing neuraminidase inhibitor drug class used to treat influenza infections.

What is the Baloxavir marboxil?

Baloxavir marboxil is , while it's Molecular Formula is C27H23F2N3O7S. Baloxavir Marboxil is a prodrug of S-033447, which is an inhibitor of the cap-dependent endonuclease of influenza A and B viruses.

What is the CAS number for Baloxavir marboxil?

The CAS number of Baloxavir marboxil is 1985606-14-1.

What is Baloxavir marboxil (1985606-14-1) used for?

Baloxavir marboxil is an antiviral drug developed by Shionogi Co., a Japanese pharmaceutical company and Roche for the treatment of influenza A and influenza B infections. The drug was initially approved for use in Japan in February 2018 and approved by the FDA on October 24, 2018 for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours Label. Baloxavir marboxil, a cap-endonuclease inhibitor, has a unique mechanism of action when compared to the currently existing neuraminidase inhibitor drug class used to treat influenza infections.